Andreas Wibmer

6PUBLICATIONS
63CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 04, 2026
Phase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer.

Susan Slovin, Xin Gao, Xiao X Wei

|Jul 08, 2022
Associations of Body Fat Distribution and Cardiometabolic Risk of Testicular Cancer Survivors After Cisplatin-Based Chemotherapy.

Andreas G Wibmer, Paul C Dinh, Lois B Travis

|Jun 07, 2022
The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer.

Goutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani

|Dec 21, 2021
Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.

Andreas G Wibmer, Ines Nikolovski, Joshua Chaim

|Jun 02, 2021
International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer.

Andreas G Wibmer, Michael W Kattan, Francesco Alessandrino

|Apr 30, 2021
Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A Systematic Review and Meta-Analysis.

Sangwon Han, Sungmin Woo, Yong-Il Kim

Pageof 1

Frequent Collaborators

2 joint publications

Michael W Kattan

2 joint publications

Hebert Alberto Vargas

2 joint publications

Hedvig Hricak

1 joint publications

Sungmin Woo